PROVOLUT

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jul 2025 filing date already counts against anyone who files later.

Record

Serial number

99266882

Mark type

Stylized text

Filed

03 Jul 2025

Published for opposition

21 Apr 2026

Attorney of record

KATRIN LEWERTOFF

Goods and services

• Class 009 — Scientific and electric apparatus: Recorded and downloadable media and data, namely, recorded and downloadable datasets comprising protein sequence, structure, and function data for use in biotechnology and pharmaceutical research; Downloadable databases in the field of protein engineering, molecular biology, and drug discovery; Downloadable software for computational protein design, protein engineering, molecular simulation, and optimization of proteins, enzymes, and molecules for pharmaceutical and industrial biotechnology applications; Downloadable artificial intelligence software for protein design, protein optimization, drug candidate identification, and prediction of protein properties and downloadable software using machine learning for designing, analyzing, optimizing, and predicting the function and properties of proteins, enzymes, and molecules for use in pharmaceutical development and biotechnology; all the aforesaid goods relating to, in particular, synthetic biology, biotechnology, protein engineering, molecular sciences and the design, development and optimization of proteins, enzymes and molecules
• Class 042 — Scientific and technological services: IT services, namely, IT consulting services relating to the implementation, integration, maintenance, and customization of software for computational biology, protein engineering, and drug design; development, programming and implementation of software for others; hosting services, namely, hosting cloud-based software platforms for computational protein design, molecular simulation, and drug discovery; platform-as-a-service (PaaS) featuring computer software platforms for computational protein engineering, machine-learning-driven protein optimization, and pharmaceutical drug candidate design and analysis; software-as-a-service (SaaS) services featuring software for AI-driven protein design, protein optimization, molecular engineering, and drug discovery; rental of computer software for computational protein design, protein optimization, molecular simulation, and drug development; design and development of computer hardware and software; scientific and technological services, namely, scientific research, computational analysis, and testing in the field of protein engineering, molecular biology, drug discovery, and biotechnology and scientific and technological research in the field of protein design, enzyme engineering, drug development, and precision oncology and design services relating thereto, namely, computational protein design, enzyme design, drug candidate design, and software design for biotechnology applications; industrial research in the field of biotechnology, protein engineering, and industrial enzyme development and industrial design services; quality control of goods and services and authentication in the field of protein and enzyme quality, pharmaceutical drug candidates, and biotechnological products; development of pharmaceutical products; Scientific laboratory services; laboratory research in the field of protein engineering, molecular biology, enzyme optimization, and pharmaceutical drug development; Scientific laboratory services; Computer software consultancy, information and information services in the field of computational biology, protein engineering, drug design, and biotechnology relating to the aforementioned services; all of the aforementioned services, in particular, in the field of synthetic biology, biotechnology, protein technology, molecular sciences and for the design, development and optimization of proteins, enzymes and molecules

Owner

• Exazyme GmbH, Berlin, DE

Prosecution history

• 24 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 24 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 24 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 24 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 24 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 24 Nov 2025 — NON-FINAL ACTION E-MAILED
• 24 Nov 2025 — NON-FINAL ACTION WRITTEN
• 21 Nov 2025 — ASSIGNED TO EXAMINER
• 09 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 03 Jul 2025 — APPLICATION FILING RECEIPT MAILED
• 03 Jul 2025 — NEW APPLICATION ENTERED